Soleus Private Equity Fund III L.P. 13D and 13G filings for Prelude Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-08 5:20 pm Purchase | 2026-04-21 | 13G | PRELUDE THERAPEUTICS INC PRLD | Soleus Private Equity Fund III L.P. | 3,378,378 5.200% | 3,378,378 (New Position) | Filing |